On November 17, Quantinuum rose 5.81% in Regular Trading, trading at $33.6 per share, with turnover of $17.33 million.
The move came as the market continued to digest the company’s recent post-earnings valuation reset, while pressure from a wave of analyst target-price cuts appeared to be easing and short-term funds returned to the stock.
Earlier this month, Quantinuum reported third-quarter revenue of $9.1 million, above market expectations, while adjusted EPS of $0.46 loss per share missed consensus. The company also raised its full-year revenue guidance to $31 million to $34 million. Even so, several firms had cut target prices after the results, including UBS to $50 from $93, alongside reductions from Mizuho, Needham, and Jefferies, which had weighed on valuation expectations in recent sessions.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments